About Anaquant
Anaquant is a Healthcare company based in Lyon (France) founded in 2014, and was acquired by Clean Cells in July 2026. It provides analysis and quantification of host cell proteins in bioprocesses. It operates on a B2B model. Anaquant offers products and services including HCPprofiler Kit, Global Host Cell Protein Analysis, READYBEADS Kits, and Protein Characterization. Its focus areas include Health Tech, Drug Development, Quantification Services and PK/PD Studies. Its competitors include Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
Anaquant specializes in host cell protein quantification and analysis using mass spectrometry services. They provide global and specific HCP analysis, protein characterization, and kits like HCPprofiler. Based in Lyon, France, they support RD projects by developing analytical methods and offering detailed reports to pharmaceutical clients for drug development and vaccine formulation.
- Headquarters Lyon, France
- Stage Acquired
- SectorsHealthcare
- Website anaquant.com
- Social LinkedIn
- Acquired by Clean Cells (Jul 2026)
- Investors
- Acquired byClean Cells
(Jul 2026)
Products & Services of Anaquant
Anaquant offers a comprehensive portfolio of products and services, including HCPprofiler Kit, Global Host Cell Protein Analysis, READYBEADS Kits, and Protein Characterization.
Kit for quantifying host cell proteins in bioprocesses.
Service analyzing host cell proteins comprehensively.
Kits for targeted host cell protein detection.
Service for intact mass and peptide mapping analysis.
Investors in Anaquant
Anaquant has secured backing from 1 investor. Prominent investors backing the company include Clean Cells.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers cell banking and virus banking services | 2000 | clean-cells.com | Bouffere, France |
Investor details for Anaquant
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Anaquant
2 dated milestones of Anaquant across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Anaquant is founded.
- Exit Acquired by Clean Cells.
Competitors of Anaquant
Anaquant has 10 listed competitors in our database, 9 of them funded. They include Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nautilus.bio | 2016 | Seattle, United States | $103.26M | 134 | A proteomics platform is developed for analyzing the human proteome. | |
| somalogic.com | 1999 | Boulder, United States | $663.99M | 319 | Protein-based assays are developed for life science research. | |
| proteinsimple.com | 2004 | San Jose, United States | $114.29M | 157 | Provider tools to help researchers with protein analysis | |
| amunix.com | 2006 | Mountain View, United States | $200.59M | 82 | Peptide-based therapeutics are developed for cancers and immune disorders. | |
| dynamic-biosensors.com | 2011 | Planegg, Germany | $5.83M | 51 | Label-free solutions for molecular interactions and biophysical analysis are provided. | |
| biognosys.com | 2008 | Schlieren, Switzerland | $9.13M | – | Proteomics services are delivered via discovery and targeted platforms. | |
| elektrofi.com | 2016 | Boston, United States | $152.25M | 71 | Digital platform transforming the delivery of biologic medicines | |
| arzeda.com | 2008 | Seattle, United States | $94.96M | 66 | Synthetic enzymes are designed using computational technology for industrial applications. | |
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| aalphabio.com | 2017 | Seattle, United States | $45.24M | 48 | Developer of cell-based tool for the measurements of protein interactions |
Detailed competitors of Anaquant
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Anaquant
The website of Anaquant (anaquant.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 103.2% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Anaquant (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Anaquant
Anaquant was founded in 2014.
Anaquant is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Anaquant specializes in host cell protein quantification and analysis using mass spectrometry services. They provide global and specific HCP analysis, protein characterization, and kits like HCPprofiler. Based in Lyon, France, they support RD projects by developing analytical methods and offering detailed reports to pharmaceutical clients for drug development and vaccine formulation.
Anaquant's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.
Anaquant offers HCPprofiler Kit, Global Host Cell Protein Analysis, READYBEADS Kits, and Protein Characterization.
Anaquant has 1 investor. Key investors include Clean Cells.
Yes. Anaquant was acquired by Clean Cells in July 2026.